NEW ZEALAND GAZETTE, No. 65 — 11 JUNE 2015

in capsules containing 60 milligrams or less of fexofenadine hydrochloride or in tablets containing 120 milligrams or less of fexofenadine hydrochloride with a maximum daily dose of 120 milligrams when sold in the manufacturer’s original pack containing 10 dosage units or less and not more than 5 days’ supply

Guaiphenesin; for oral use in medicines containing 2% or less or 200 milligrams or less per dose form; for oral use in modified release form with a maximum recommended daily dose of not more than 2.4 grams when sold in the manufacturer’s original pack containing not more than 10 days’ supply

Human protein C

Ibuprofen; for external use; in divided solid dosage forms for oral use containing 200 milligrams or less per dose form with a recommended daily dose of not more than 1.2 grams and when sold in the manufacturer’s original pack containing not more than 25 dose units per pack

Isoconazole; for dermal use when sold in practice by a podiatrist registered with the Podiatrists Board

Ketoconazole; for dermal use in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board; in medicines for treatment of the scalp containing 1% or less

Loratadine; in divided solid dosage forms for oral use containing 10 milligrams or less per dose form for the treatment of seasonal allergic rhinitis when sold in the manufacturer’s original pack containing not more than 5 days’ supply

Mepyramine; for external use in medicines containing 2% or less in packs not exceeding 25 grams

Miconazole; for external use in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

Nystatin; for dermal use when sold in practice by a podiatrist registered with the Podiatrists Board

Oxymetazoline; for nasal use when sold at an airport; for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; for nasal use in medicines containing 0.05% or less when sold in the manufacturer’s original pack with a pack size of 20 millilitres or less

Ranitidine; in medicines containing 150 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than 7 days’ supply

Terbinafine; for dermal use in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

Tioconazole; for dermal use in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

Turoctocog alfa

Dated this 9th day of June 2015.

Dr STEWART JESSAMINE, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health.

2015-go3438

Justices of the Peace Appointed

Pursuant to section 3(1) of the Justices of the Peace Act 1957, His Excellency the Governor-General of New Zealand has been pleased to appoint the following persons to be Justices of the Peace for New Zealand:

Allison, Christopher John, 134 Seaward Road, Edendale.

Arnold, Andrew Jonathan, 39 Balmoral Street, Taradale, Napier.

Bates, Danny Michael, 131 Warwick Road, RD 21, Stratford.

Benton, Jillian Margaret, 32B Rawhitiroa Road, Kohimarama, Auckland.

Bremner, Shelley, 48 Alexander Avenue, Whakatane.

Buckland, Wayne Russell, 20 Ata Mahina Way, Ruakaka.

Chand, Rupen, 31 Stewart Road, Mount Albert, Auckland.

Chen, Huang Hsiang, 1/24 Wharenui Road, Upper Riccarton, Christchurch.

Cook, Melvin Sydney, 86 Dudley Road, RD 6, Inglewood.

Cortes-Vela, Marlene Elizabeth, 3A Aspen Grove, Fernhill, Queenstown.

Futter, Mark David, 7 Richmond Street, Wallaceville, Upper Hutt.

Gauld, Barbara Joan, 8 McCrystal Avenue, Bucklands Beach, Auckland.

67